TriSalus Life Sciences Warrant
TLSIW
24 hedge funds and large institutions have $238K invested in TriSalus Life Sciences Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
17% less funds holding
Funds holding: 29 → 24 (-5)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
91% less capital invested
Capital invested by funds: $2.59M → $238K (-$2.35M)
Top Buyers
| 1 |
CF
Cantor Fitzgerald
New York
|
+$5.44K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$918 |
| 3 |
FSI
Flow State Investments
Chicago,
Illinois
|
+$438 |
Top Sellers
| 1 |
CS
Clear Street
New York
|
-$21.4K |
| 2 |
AGC
Angelo Gordon & Co
New York
|
-$8.45K |
| 3 |
IM
Islet Management
New York
|
-$4.89K |
| 4 |
AGM
Alpine Global Management
New York
|
-$1K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$935 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AGC
26
Angelo Gordon & Co
New York
| – | -$8.45K | -95,808 | Closed |
|
|
IM
27
Islet Management
New York
| – | -$4.89K | -65,158 | Closed |
|
|
OMC
28
Old Mission Capital
Chicago,
Illinois
| – | -$935 | -12,479 | Closed |
|
|
AGM
29
Alpine Global Management
New York
| – | -$1K | -11,600 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$4 | -49 | Closed |
|
TLSIW Hedge Fund Activity: Q1 2023 in Review
24 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2023, worth a combined $238K — down 91% from $2.59M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TLSIW and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $5.44K. The largest seller was Clear Street, cutting an estimated $21.4K.
- 24 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2023, down from 29 in Q4 2022.
- Funds reported $238K of TriSalus Life Sciences Warrant stock for Q1 2023, down 91% quarter-over-quarter.
- 2 funds opened new TriSalus Life Sciences Warrant positions in Q1 2023 and 5 closed out, a net change of -3 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q1 2023 was Cantor Fitzgerald, an estimated $5.44K added.
- The largest TriSalus Life Sciences Warrant seller in Q1 2023 was Clear Street, an estimated $21.4K sold.
Based on aggregated 13F filings for Q1 2023.